Detection of dynamic frequencies of Th17 cells and their associations with clinical parameters in patients with systemic lupus erythematosus receiving standard therapy

Clinical Rheumatology

Volumn 33, Issue 10, 2014, Pages 1451-1458

  Wen, Zhenke ^a   Xu, Lin ^a   Xu, Wei ^b   Xiong, Sidong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

anti dsDNA antibody; SLEDAI; Systemic lupus erythematosus; Th17 cells

Indexed keywords

CHLOROQUINE; COMPLEMENT COMPONENT C3; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; MESSENGER RNA; STAT3 PROTEIN; ANTIBODY; BIOLOGICAL MARKER; DNA;

ADULT; ANTIBODY PRODUCTION; ARTHRITIS; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; DYNAMICS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; KIDNEY DISEASE; MALAR RASH; MOUTH ULCER; NEUROLOGIC DISEASE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RASH; REAL TIME POLYMERASE CHAIN REACTION; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; BLOOD; CASE CONTROL STUDY; CELL COUNT; CELL PROLIFERATION; DISABILITY; ERYTHROCYTE SEDIMENTATION RATE; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; ANTIBODIES; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; CASE-CONTROL STUDIES; CELL COUNT; CELL PROLIFERATION; CHLOROQUINE; COMPLEMENT C3; DISABILITY EVALUATION; DNA; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TH17 CELLS;

EID: 84937511954     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2656-5     Document Type: Article

References (38)

1. Chung SA, Taylor KE, Graham RR et al (2011) Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet 7:e1001323
2. Cook HT, Botto M (2006) Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat Clin Pract Rheumatol 2:330–337
3. Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. N Engl J Med 358:929–939
4. Wiesik-Szewczyk E, Olesinska M (2012) B-cell targeted therapy in systemic lupus erythematosus: Potential of rituximab. Biologics 6:347–354
5. Ahearn JM, Liu CC, Kao AH, Manzi S (2012) Biomarkers for systemic lupus erythematosus. Transl Res 159:326–342
6. Liu CC, Ahearn JM (2009) The search for lupus biomarkers. Best Pract Res Clin Rheumatol 23:507–523
7. Schiffenbauer J, Hahn B, Weisman MH, Simon LS (2004) Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus. Arthritis Rheum 50:2415–2422
8. Das N, Biswas B, Khera R (2013) Membrane-bound complement regulatory proteins as biomarkers and potential therapeutic targets for SLE. Adv Exp Med Biol 735:55–81
9. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S (2012) Defining the human T helper 17 cell phenotype. Trends Immunol 33:505–512
10. Garrett-Sinha LA, John S, Gaffen SL (2008) IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol 20:519–525
11. Jacob N, Yang H, Pricop L et al (2009) Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway. J Immunol 182:2532–2541
12. Hemdan NY, Birkenmeier G, Wichmann G et al (2010) Interleukin-17-producing T helper cells in autoimmunity. Autoimmun Rev 9:785–792
13. Shah K, Lee WW, Lee SH et al (2010) Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res Ther 12:R53
14. Henriques A, Inês L, Couto M et al (2010) Frequency and functional activity of Th17, Tc17, and other T-cell subsets in systemic lupus erythematosus. Cell Immunol 264:97–103
15. Chen XQ, Yu YC, Deng HH et al (2010) Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity. J Clin Immunol 30:221–225
16. Kang HK, Liu M, Datta SK (2007) Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J Immunol 178:7849–7858
17. Wu HY, Quintana FJ, Weiner HL (2008) Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+, CD25−, LAP+ regulatory T cell and is associated with down-regulation of IL-17+, CD4+, ICOS+, CXCR5+ follicular helper T cells. J Immunol 181:6038–6050
18. Vega L, Barbado J, Almansa R et al (2010) Prolonged standard treatment for systemic lupus erythematosus fails to normalize the secretion of innate immunity-related chemokines. Eur Cytokine Netw 21:71–76
19. Prado C, de Paz B, Gómez J et al (2011) Glucocorticoids enhance Th17/Th1 imbalance and signal transducer and activator of transcription 3 expression in systemic lupus erythematosus patients. Rheumatology (Oxford) 50:1794–1801
20. Liu M, Hu X, Wang Y et al (2009) Effect of high-dose methylprednisolone treatment on Th17 cells in patients with multiple sclerosis in relapse. Acta Neurol Scand 120:235–241
21. Hemdan NY, Birkenmeier G, Wichmann G (2012) Key molecules in the differentiation and commitment program of T helper 17 (Th17) cells up-to-date. Immunol Lett 148:97–109
22. Sallusto F, Zielinski CE, Lanzavecchia A (2012) Human Th17 subsets. Eur J Immunol 42:2215–2220
23. Wen Z, Xu L, Xu W, Xiong S (2012) Production of anti-double-stranded DNA antibodies in activated lymphocyte derived DNA induced lupus model was dependent on CD4+ T cells. Lupus 21:508–516
24. Wen Z, Xu L, Xu W et al (2013) Interleukin-17 expression positively correlates with disease severity of lupus nephritis by increasing anti-double-stranded DNA antibody production in a lupus model induced by activated lymphocyte derived DNA. PLoS One 8:e58161
25. Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 cells. Annu Rev Immunol 27:485–517
26. Gaffen SL (2011) Recent advances in the IL-17 cytokine family. Curr Opin Immunol 23:613–619
27. Yang XY, Wang HY, Zhao XY et al (2013) Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus. J Clin Immunol 33:767–774
28. Chen DY, Chen YM, Wen MC et al (2012) The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis. Lupus 21:1385–1396
29. Miyake K, Akahoshi M, Nakashima H (2011) The subset balance in lupus nephritis. J Biomed Biotechnol 2011:980286
30. Apostolidis SA, Crispín JC, Tsokos GC (2011) IL-17-producing T cells in lupus nephritis. Lupus 20:120–124
31. Nakae S, Komiyama Y, Nambu A et al (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375–387
32. Hsu HC, Yang P, Wang J et al (2008) Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9:166–175
33. Doreau A, Belot A, Bastid J, Riche B et al (2009) Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 10:778–785
34. Xie S, Li J, Wang JH et al (2010) IL-17 activates the canonical NF-kappaB signaling pathway in autoimmune B cells of BXD2 mice to upregulate the expression of regulators of G-protein signaling 16. J Immunol 184:2289–2296
35. Mitsdoerffer M, Lee Y, Jäger A et al (2010) Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A 107:14292–14297
36. Barbosa RR, Silva SP, Silva SL et al (2011) Primary B-cell deficiencies reveal a link between human IL-17-producing CD4 T-cell homeostasis and B-cell differentiation. PLoS One 6:e22848
37. Mountz JD, Wang JH, Xie S, Hsu HC (2011) Cytokine regulation of B-cell migratory behavior favors formation of germinal centers in autoimmune disease. Discov Med 11:76–85
38. Hickman-Brecks CL, Racz JL, Meyer DM, LaBranche TP, Allen PM (2011) Th17 cells can provide B cell help in autoantibody induced arthritis. J Autoimmun 36:65–75